Search Results for "Treatment Of Neurofibroma In India"

11:42 EDT 27th May 2015 | BioPortfolio

Matching Channels


India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to:    

Specific treatment

Dysrhythmia Treatment

Matching News

Mylan Launches Sovaldi Tablets in India

​Mylan N.V. announced that its subsidiary, Mylan Pharmaceuticals Private Ltd, has launched Gilead Sciences' Sovaldi (sofosbuvir 400mg tablets) in India. Sovaldi is indicated for the treatment of chr...

Mylan and Gilead partner for Sovaldi and Harvoni in India

Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India. ...

Hetero Received Generic Sofosbuvir (Gilead's Sovaldi) Approval From Drug Controller General of India (DCGI)

HYDERABAD, INDIA -- (Marketwired) -- 03/12/15 -- Hetero, a leading pharmaceutical company based in Hyderabad, India, today announced that it has received approval for generic Sofosbuvir Tablets, 400...

'Responsibly' priced Invokana debuts in India

The daily cost of therapy with Invokana in India is INR51 ($0.8), generally comparable with the newer treatment options available in the country and a fraction of the product's US cost, reported in so...

Canada, India fund 5 innovations to improve health in India, with focus on mothers and children

(Terry Collins Assoc) Canada and India today announced investments of CDN $2.5 million in five innovations in India aimed primarily at improving maternal, newborn and child health -- Canada's flagship...

BioAsia 2015: Fixes To India’s Medicines Access Issue

Access to medicines is a hot button topic in India. The government has spoken on interventions like establishing low cost generic drug stores, while the industry is toying with financing models to imp...

Medics in Rural India Unaware of Correct Treatment for Childhood Infections

A vast majority of healthcare providers in Bihar province of northern India interviewed for a recent study were unaware of the appropriate treatments for diarrhea and pneumonia, the biggest contributo...

India is ready to invest in Eastern Europe’s pharmaceutical industry

According to Manoj Kumar Bharti, Ambassador Extraordinary and Plenipotentiary of India to Belarus, India companies are ready to invest in pharmaceutical production in Belarus. India has world reno...

Matching PubMed Articles

Self-Administered Tuberculosis Treatment Outcomes in a Tribal Population on the Indo-Myanmar Border, Nagaland, India.

Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage of tuberculosis treatment. However, populations living in 'hard-to-reach' areas of north-ea...

Extensive Plexiform Neurofibroma in a Premature Neonate.

We describe a premature neonate with an extensive plexiform neurofibroma. Prenatal ultrasound at 32 weeks of gestation was normal. Postnatal examination was significant for a palpable left neck mass. ...

TB Treatment Delays in Odisha, India: Is It Expected Even after These Many Years of RNTCP Implementation?

In India, the Revised National TB Control Programme (RNTCP) envisages initiation of TB treatment within seven days of diagnosis among smear-positive patients. After nearly two decades of RNTCP impleme...

Solitary Epibulbar Neurofibroma in Older Adult Patients.

To report a solitary epibulbar neurofibroma in 2 elderly patients without systemic neurofibromatosis.

Ketotifen suppression of NF1 neurofibroma growth over 30 years.

A patient with NF1 was treated with oral ketotifen for 30 years since infancy. Review of the patient's course and treatment details establishes a basis for reconsideration of several fundamental prece...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement